For every dollar spent on Nvidia, Wedbush estimates an eight-to-ten times amplification effect across the rest of the tech ...

Investing.com -- Fitch Ratings has affirmed Angola’s Long-Term Foreign-Currency Issuer Default Rating at ’B-’ with a Stable ...

Investing.com -- Ron Baron, the billionaire investor who has been one of Tesla’s most vocal long-term backers, laid out an ultra-bullish trajectory for the company’s stock in a new interview to CNBC, ...

Investing.com -- Berkshire Hathaway disclosed a $4.3 billion stake in Google’s parent Alphabet, making the company its 10th largest equity holding as of September 30, according to a regulatory filing ...

Investing.com -- U.S. liquefied natural gas (LNG) plants could consume 40 billion cubic feet of natural gas per day in the coming years, according to Cheniere Energy ’s chief commercial officer Anatol ...

Investing.com -- U.S. energy firms added oil and natural gas rigs for a second consecutive week, according to Baker Hughes’ report released Friday. The total oil and gas rig count, which serves as an ...

Investing.com -- French Commerce Minister Serge Papin revealed that a consumer watchdog identified six online platforms selling illicit products in France, according to an interview published in Le ...

Investing.com -- Gold prices rose Thursday, extending recent gains as traders remained uncertain over the U.S. economy even ...

OPEC has steadily ramped up production so far this year, and plans to increase production further in December. While the cartel did outline plans to halt any further production increases in Q1 2026, ...

The Bureau of Labor Statistics (BLS) has announced revised release dates for key economic reports following the government shutdown. The Employment Situation repo ...

Investing.com -- Google plans to invest $40 billion to build three new data centers in Texas by 2027, Bloomberg reported Friday, expanding its infrastructure as AI competition intensifies.

Investing.com -- Sarepta Therapeutics (NASDAQ:SRPT) stock rose 7% after the U.S. Food and Drug Administration approved new labeling for its gene therapy Elevidys that includes a Boxed Warning and ...